123 related articles for article (PubMed ID: 28190919)
1. Heterogeneity of tumor cells in terms of cancer-initiating cells.
Morii E
J Toxicol Pathol; 2017 Jan; 30(1):1-6. PubMed ID: 28190919
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells.
Ikeda J; Mamat S; Tian T; Wang Y; Luo W; Rahadiani N; Aozasa K; Morii E
Lab Invest; 2012 Apr; 92(4):606-14. PubMed ID: 22349638
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.
Takaya A; Hirohashi Y; Murai A; Morita R; Saijo H; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Tamura Y; Takemasa I; Kondo T; Sato N; Torigoe T
PLoS One; 2016; 11(7):e0158903. PubMed ID: 27415781
[TBL] [Abstract][Full Text] [Related]
4. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
Morrison BJ; Steel JC; Morris JC
BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
[TBL] [Abstract][Full Text] [Related]
5. Plasma-activated medium (PAM) kills human cancer-initiating cells.
Ikeda JI; Tanaka H; Ishikawa K; Sakakita H; Ikehara Y; Hori M
Pathol Int; 2018 Jan; 68(1):23-30. PubMed ID: 29235204
[TBL] [Abstract][Full Text] [Related]
6. Differential remodeling of extracellular matrices by breast cancer initiating cells.
Raja AM; Xu S; Zhuo S; Tai DC; Sun W; So PT; Welsch RE; Chen CS; Yu H
J Biophotonics; 2015 Oct; 8(10):804-15. PubMed ID: 25597396
[TBL] [Abstract][Full Text] [Related]
7. Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.
Shidal C; Al-Rayyan N; Yaddanapudi K; Davis KR
Oncotarget; 2016 Dec; 7(51):84128-84141. PubMed ID: 27566591
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Maccalli C; Parmiani G; Ferrone S
Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
[TBL] [Abstract][Full Text] [Related]
9. MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.
Yasuda K; Hirohashi Y; Kuroda T; Takaya A; Kubo T; Kanaseki T; Tsukahara T; Hasegawa T; Saito T; Sato N; Torigoe T
Biochem Biophys Res Commun; 2016 Apr; 472(4):643-7. PubMed ID: 26969274
[TBL] [Abstract][Full Text] [Related]
10. Targeting the cancer initiating cell: the ultimate target for cancer therapy.
McCubrey JA; Steelman LS; Abrams SL; Misaghian N; Chappell WH; Basecke J; Nicoletti F; Libra M; Ligresti G; Stivala F; Maksimovic-Ivanic D; Mijatovic S; Montalto G; Cervello M; Laidler P; Bonati A; Evangelisti C; Cocco L; Martelli AM
Curr Pharm Des; 2012; 18(13):1784-95. PubMed ID: 22394167
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma.
Tabuchi Y; Hirohashi Y; Hashimoto S; Mariya T; Asano T; Ikeo K; Kuroda T; Mizuuchi M; Murai A; Uno S; Kawai N; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Saito T; Torigoe T
Exp Mol Pathol; 2019 Feb; 106():78-88. PubMed ID: 30503404
[TBL] [Abstract][Full Text] [Related]
12. Possible role of mural cell-covered mature blood vessels in inducing drug resistance in cancer-initiating cells.
Matsui T; Kinugasa Y; Tahara H; Kanakura Y; Takakura N
Am J Pathol; 2013 May; 182(5):1790-9. PubMed ID: 23473746
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of Nodal on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma of uterus.
Wang Y; Jiang Y; Tian T; Hori Y; Wada N; Ikeda J; Morii E
Biochem Biophys Res Commun; 2013 Nov; 440(4):731-6. PubMed ID: 24120944
[TBL] [Abstract][Full Text] [Related]
14. Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.
Asano T; Hirohashi Y; Torigoe T; Mariya T; Horibe R; Kuroda T; Tabuchi Y; Saijo H; Yasuda K; Mizuuchi M; Takahashi A; Asanuma H; Hasegawa T; Saito T; Sato N
Oncotarget; 2016 Mar; 7(10):11223-37. PubMed ID: 26849232
[TBL] [Abstract][Full Text] [Related]
15. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.
Tallerico R; Todaro M; Di Franco S; Maccalli C; Garofalo C; Sottile R; Palmieri C; Tirinato L; Pangigadde PN; La Rocca R; Mandelboim O; Stassi G; Di Fabrizio E; Parmiani G; Moretta A; Dieli F; Kärre K; Carbone E
J Immunol; 2013 Mar; 190(5):2381-90. PubMed ID: 23345327
[TBL] [Abstract][Full Text] [Related]
16. Active Component of Antrodia cinnamomea Mycelia Targeting Head and Neck Cancer Initiating Cells through Exaggerated Autophagic Cell Death.
Chang CW; Chen CC; Wu MJ; Chen YS; Chen CC; Sheu SJ; Lin TW; Chou SH; Lin SC; Liu CJ; Lee TC; Huang CY; Lo JF
Evid Based Complement Alternat Med; 2013; 2013():946451. PubMed ID: 23843890
[TBL] [Abstract][Full Text] [Related]
17. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.
Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
Front Oncol; 2022; 12():906415. PubMed ID: 35982950
[TBL] [Abstract][Full Text] [Related]
18. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal.
Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N
Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638
[TBL] [Abstract][Full Text] [Related]
19. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.
Ravindran S; Rasool S; Maccalli C
Cancer Microenviron; 2019 Dec; 12(2-3):133-148. PubMed ID: 31758404
[TBL] [Abstract][Full Text] [Related]
20. ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells.
Chang CW; Chen YS; Tsay YG; Han CL; Chen YJ; Yang CC; Hung KF; Lin CH; Huang TY; Kao SY; Lee TC; Lo JF
Cell Death Dis; 2018 Feb; 9(2):194. PubMed ID: 29416012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
